Back To Search Results

Pfeiffer Syndrome

Editor: Ryan Winters Updated: 6/2/2025 8:00:01 PM

Introduction

Pfeiffer syndrome (Online Mendelian Inheritance in Man [OMIM] #101600; also called type 5 acrocephalosyndactyly, craniofacial-skeletal-dermatologic dysplasia, or Noack syndrome) is a hereditary craniofacial disorder characterized by primary craniosynostosis, midface hypoplasia, broad thumbs and great toes, and varying degrees of soft tissue syndactyly of the hands (typically involving the second and third digits) and feet.[1] The syndrome was first described in 1964 by Rudolf Pfeiffer, who reported 8 cases across 3 generations of a single family.[2] Clinical features included acrocephalosyndactyly, hypertelorism, antimongoloid slant, and normal intelligence. The observation of male-to-male transmission supported an autosomal dominant mode of inheritance. Most affected individuals also present with associated conductive hearing loss. Acrocephalosyndactyly syndromes involving premature closing of the cranial sutures are:

  • Type 1: Apert syndrome
  • Type 2: Vogt/Crouzon syndrome
  • Type 3: Saethre–Chotzen syndrome
  • Type 4: Waardenburg syndrome
  • Type 5: Pfeiffer syndrome

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Pfeiffer syndrome exhibits autosomal dominant inheritance with complete penetrance and variable expressivity, particularly in the presentation of syndactyly.[3] The severity and combination of craniofacial and limb abnormalities can differ significantly even among affected individuals within the same family. Pfeiffer syndrome type 1 is associated with mutations in the FGFR1 and FGFR2 genes. Types 1 and 3 are linked exclusively to FGFR2 mutations, and most cases result from mutations in the FGFR2 gene located on chromosome 10q26.13. Mutations in the FGFR1 gene, located on chromosome 8p11.23, account for a small percentage of type 1 cases and are typically not associated with other Pfeiffer syndrome types.

The FGFR1 and FGFR2 genes encode fibroblast growth factor receptors 1 and 2, respectively. These receptors play a critical role in embryonic development, particularly in the differentiation of pluripotent stem cells into osteoblasts. Mutations can result in prolonged receptor signaling, leading to premature cranial suture fusion and abnormal development of the extremities.

There are 4 major FGFR2 mutations commonly associated with severe forms of Pfeiffer syndrome (p.W290C, p.Y340C, p.C342R, and p.S351C). In contrast, the FGFR1 mutation p.P252R is typically associated with a milder phenotype.[4] A well-characterized mutation in Pfeiffer syndrome is p.Pro252Arg, located in exon 5 of the FGFR1 gene.[5] One major risk factor for the development of Pfeiffer syndrome is advanced paternal age. The risk of transmission from an affected parent to offspring is 50% for each pregnancy, consistent with autosomal dominant inheritance. Both males and females are equally affected.

Epidemiology

Pfeiffer syndrome affects 1 in 100,000 newborns.[6] This condition is the second most common form of the acrocephalosyndactyly syndromes, with Apert syndrome being the most prevalent.[7]

Pathophysiology

A cloverleaf skull usually results from the premature closure of the coronal and lambdoid sutures. Bicoronal synostosis can lead to skull base hypoplasia and reduced intracranial volume, subsequently causing elevated intracranial pressure, which can present with symptoms such as headaches or visual disturbances. Characteristic facial features of Pfeiffer syndrome result from the premature fusion of the cranial bones. Abnormal craniofacial development leads to proptosis, wide-set eyes, a high forehead, an underdeveloped maxilla, and a beaked nose. Patients with Pfeiffer syndrome may experience upper airway obstruction related to midface hypoplasia and secondary nasal obstruction.

Maxillary hypoplasia reduces intraorbital volume, leading to proptosis, xerophthalmia, and exposure keratitis. Visual disturbances may arise from extraocular muscle imbalance secondary to proptosis or elevated intracranial pressure. Hearing loss in Pfeiffer syndrome can result from recurrent ear infections, middle ear hypoplasia, or auditory canal atresia. Additionally, maxillary hypoplasia contributes to narrowing of the nasopharynx, oropharynx, and larynx, which can cause snoring, nasal regurgitation, aspiration of food, and obstructive sleep apnea.

History and Physical

The physical examination in Pfeiffer syndrome typically reveals craniosynostosis, midface hypoplasia, broad thumbs and great toes, and soft tissue syndactyly. Additional features—such as proptosis, elbow ankylosis, and cloverleaf skull deformity—may be present in more severe forms of the condition. Physical features vary by subtype, making careful examination essential for accurate classification and management (see Table. Comparison of Pfeiffer Syndrome Types).

Pfeiffer syndrome type 1 is characterized by brachycephaly resulting from bicoronal synostosis, maxillary hypoplasia, hypertelorism, prognathism, and dental anomalies. Limb features include broad thumbs and great toes, variable brachydactyly-syndactyly, with normal intelligence typically preserved. Pfeiffer syndrome type 2 presents with more severe manifestations, including a cloverleaf skull (Kleeblattschädel type craniosynostosis), which is typically associated with hydrocephalus, maxillary hypoplasia resulting in proptosis, a “beak-shaped” nose, inferiorly positioned ears, and elbow joint ankylosis.[8] Hydrocephalus in these patients may result from venous hypertension, sleep apnea, cerebrospinal fluid obstruction due to acqueductal stenosis or basilar invagination, or from posterior fossa abnormalities. This form is usually associated with significant neurological and cognitive impairment, as well as visceral abnormalities.

The clinical features of Pfeiffer syndrome type 3 are similar to those of type 2, except for the presence of a cloverleaf skull deformity. Additional features may include a short anterior cranial fossa, natal teeth, pronounced proptosis, and various visceral abnormalities, such as hydronephrosis, pelvic kidneys, and hypoplastic gallbladder. Patients with type 3 may also exhibit cognitive and neurological impairments and are at risk of developing seizures postnatally.

Tracheal cartilaginous sleeve (TCS) is a congenital airway malformation observed in Pfeiffer syndrome, characterized by the absence of distinct tracheal rings. Instead, a continuous segment of cartilage extends from the subglottis to the carina. This anomaly is also seen in Apert and Crouzon syndromes. The presence of TCS can worsen the prognosis due to the associated respiratory complications.[9][10]

Although craniosynostosis is the primary neurological manifestation of Pfeiffer syndrome, other central nervous system anomalies are also commonly observed. These may include abnormal white matter development, megalencephaly, occipital encephalocele, agenesis of the corpus callosum, and Chiari 1 malformation.[11][12][13][14][15] Spinal abnormalities such as butterfly vertebrae, vertebral fusion, and sacrococcygeal extension may also be present.[16][17]

Additional anomalies that may be observed in Pfeiffer syndrome include cleft palate, choanal atresia, tracheomalacia, and imperforate anus. The primary ophthalmological findings associated with the syndrome are proptosis, strabismus, papilledema, and iris colobomas.[18]

Table. Comparison of Pfeiffer Syndrome Types

Feature Type 1 (Classic) Type 2 Type 3
Skull Shape Brachycephaly (bicoronal synostosis)

Cloverleaf skull (Kleeblattschädel)

Normal or misshapen skull (no cloverleaf)

Facial Features

Maxillary hypoplasia, hypertelorism, prognathism, dental anomalies

Severe maxillary hypoplasia, proptosis, beak-shaped nose, inferiorly displaced ears

Short anterior cranial fossa, proptosis, natal teeth

Limb Abnormalities

Broad thumbs and great toes, variable brachydactyly, and syndactyly

Same as type 1, may include elbow ankylosis

 Similar to type 2
Neurological Involvement

Normal intelligence

Mental and neurological impairment, possible hydrocephalus

Mental and neurological maldevelopment, seizures may occur postnatally

Visceral Abnormalities

Rare

Common: May include cardiac, renal, and gastrointestinal anomalies

Hydronephrosis, pelvic kidneys, hypoplastic gallbladder 
Hydrocephalus

Not typical

Common; due to venous hypertension, cerebral spinal fluid obstruction, sleep apnea, or posterior fossa anomalies

May occur
Inheritance

Autosomal dominant

Sporadic (usually de novo FGFR2 mutations)

Sporadic (usually de novo FGFR2 mutations)

Prognosis

Generally good with surgical intervention

Poor due to severe neurological and systemic complications

Poor to guarded, depending on severity

Evaluation

The diagnosis of Pfeiffer syndrome is primarily clinical, based on the presence of craniosynostosis and brachysyndactyly along with characteristic craniofacial and limb abnormalities. A provisional diagnosis may be made on clinical grounds; however, confirmation requires genetic testing. Molecular analysis should include mutation screening of FGFR1 (exon 7), FGFR2 (exons 8 and 10), and FGFR3 (exon 7).[6]

Sonographic features of Pfeiffer syndrome include craniofacial anomalies such as brachycephaly, acrocephaly, craniosynostosis, hypertelorism, a small nose, and a low nasal bridge. Limb abnormalities, including syndactyly, broad thumbs, and enlarged great toes, may also be detected.[19] Ultrasound has also been proposed as a potential screening tool for the early detection of TCS in patients with suspected Pfeiffer syndrome.[20][21][22][23]

Treatment / Management

The primary goals of surgical intervention in Pfeiffer syndrome are to decompress the brain by increasing intracranial volume, expand the infraorbital space to accommodate the globes, and enlarge the nasopharyngeal airway through advancement of the nasomaxillary-zygomatic complex.[24] These surgeries are typically performed in stages and require a multidisciplinary approach involving neurosurgery, craniofacial surgery, and otolaryngology to optimize both functional and aesthetic outcomes. (B3)

Multiple-stage surgeries constitute the standard treatment approach for patients with Pfeiffer syndrome. A suturectomy may be performed within the first year of life to "unlock" fused sutures, promoting continued brain growth and reducing intracranial pressure.[25] Cosmetic surgical corrections can also be undertaken for associated abnormalities. More commonly, extensive cranial vault reconstructions are necessary due to the involvement of multiple fused sutures. These include procedures such as LeFort osteotomies, monobloc osteotomies, fronto-orbital advancements, and posterior vault distraction osteogenesis.[26](B3)

Hydrocephalus in patients with Pfeiffer syndrome is typically managed with cerebrospinal fluid shunting. Results from a recent study demonstrated that individuals with Pfeiffer syndrome are more likely to require shunt placement and experience a higher rate of shunt revisions compared to those with other craniofacial syndromes[27]. Furthermore, patients with TCS often require tracheostomy, mainly to treat obstructive sleep apnea resulting from maxillary hypoplasia, choanal stenosis, and macroglossia. The rigidity of the trachea in these individuals complicates the proper sizing of tracheostomy tubes, posing additional challenges in airway management. In some cases, even after midfacial surgical correction, prolonged ventilatory support in the intensive care setting may be necessary.[28] Counseling the parents of children with TCS regarding the potential need for tracheostomy is essential, as it can significantly impact both long-term prognosis and quality of life. (B3)

Differential Diagnosis

The main differential diagnoses of Pfeiffer syndrome are other craniosynostosis syndromes. These include:

  • Apert syndrome
  • Crouzon syndrome
  • Muenke syndrome
  • Saethre-Chotzen syndrome
  • Jackson-Weiss syndrome
  • Antley-Bixler syndrome

Pfeiffer syndrome is closely related to Apert syndrome; however, they are genetically distinct conditions. Unlike Pfeiffer syndrome, Apert syndrome typically does not present with a cloverleaf skull or proptosis. Crouzon syndrome, another related craniosynostosis disorder, lacks the limb anomalies characteristic of Pfeiffer syndrome. Phenotypic overlap may occur with Muenke syndrome, which is caused by a specific FGFR3 mutation. Other differential diagnoses include Saethre-Chotzen syndrome and Jackson-Weiss syndrome, as both may present with broad toes, a feature also seen in Pfeiffer syndrome.[6]

Antley-Bixler syndrome is a rare craniosynostosis syndrome characterized by certain clinical features that may overlap with those of Pfeiffer syndrome type 2; it is an autosomal recessive condition associated with craniosynostosis (without the cloverleaf skull deformity), radiohumeral synostosis (rather than complete elbow ankylosis), femoral bowing, and a range of visceral anomalies. Notably, the visceral anomalies seen in Antley-Bixler syndrome are usually genital.[7]

Prognosis

Type 1 Pfeiffer syndrome has a relatively favorable prognosis in terms of intellectual development. In contrast, types 2 and 3 are associated with a significantly poorer prognosis due to severe neurodevelopmental complications, and childhood mortality is common in these cases.[7] A patient’s prognosis depends on the severity of the syndrome; however, craniofacial appearance usually improves with age. More recently, Robin et al examined the clinical course of 7 children with Pfeiffer syndrome type 3 and found that, despite severe manifestations, favorable outcomes were achieved with aggressive medical and surgical management.[29]

Complications

The primary complications associated with Pfeiffer syndrome include:

  • Maldevelopment of the brain
  • Cognitive delay
  • Aspiration pneumonia
  • Corneal ulcers and erosions due to proptosis
  • Obstructive sleep apnea
  • Seizures

Deterrence and Patient Education

While Pfeiffer syndrome is primarily caused by de novo mutations, particularly in the FGFR1 and FGFR2 genes, a subset of cases follows an autosomal dominant inheritance pattern. Therefore, genetic counseling plays a critical role in deterrence, especially for individuals with a family history of craniosynostosis syndromes. Advanced paternal age has been identified as a significant risk factor for de novo mutations, and prospective parents should be educated about this association during preconception counseling.

Patient and family education is essential for managing expectations and promoting long-term care coordination. Families should be informed about the variable expressivity of the syndrome and the need for ongoing, multidisciplinary intervention involving genetics, neurosurgery, craniofacial surgery, otolaryngology, ophthalmology, and developmental pediatrics. Education should also address the potential need for multiple surgeries, long-term respiratory support (especially in TCS cases), and the importance of early developmental interventions. Clear, empathetic communication can help families navigate complex medical decisions and improve the overall quality of life for the patient.

Pearls and Other Issues

Key facts to keep in mind about Pfeiffer syndrome include the following:

  • Pfeiffer syndrome is a genetic disorder characterized by craniosynostosis, broad and medially deviated thumbs and great toes, and varying degrees of soft tissue syndactyly.
  • This is an inherited autosomal dominant condition, often associated with mutations in the FGFR1 and FGFR2 genes.
  • There are 3 clinical subtypes: Type 1 (classic) has a milder phenotype with normal intelligence; types 2 and 3 are more severe and often associated with neurological impairment, cloverleaf skull (in type 2), and early mortality.
  • Advanced paternal age is a risk factor due to the increased likelihood of new FGFR mutations.
  • Craniosynostosis can lead to increased intracranial pressure, hydrocephalus, and characteristic facial features including proptosis and midface hypoplasia.
  • Diagnosis is clinical but confirmed with genetic testing for FGFR1 and FGFR2 mutations.
  • Management involves staged surgical interventions to correct cranial and facial deformities and to relieve intracranial pressure.
  • Tracheostomy may be required in cases of airway obstruction, especially those with TCS.
  • Prognosis depends on the subtype, with type 1 generally having a favorable outcome and types 2 and 3 often associated with poor neurodevelopmental outcomes and early death.

Enhancing Healthcare Team Outcomes

An interprofessional approach to care—encompassing neurosurgery, pediatrics, orthopedics, plastic surgery, optometry, and ophthalmology—offers the best outcomes for patients with Pfeiffer syndrome. Comprehensive care should include individualized special education programs designed to assess each child’s strengths and weaknesses, followed by targeted strategies to support areas of difficulty. Holistic management also involves physiotherapy, occupational therapy, speech therapy, and specialized support for visually impaired individuals. Educational accommodations such as modified curricula and adaptive learning environments are essential for school-aged children. Developmental nurses play a key role in ongoing care by monitoring progress, coordinating services, and facilitating appropriate referrals.

References


[1]

Tokumaru AM, Barkovich AJ, Ciricillo SF, Edwards MS. Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR. American journal of neuroradiology. 1996 Apr:17(4):619-30     [PubMed PMID: 8730180]

Level 2 (mid-level) evidence

[2]

PFEIFFER RA. [DOMINANT HEREDITARY ACROCEPHALOSYNDACTYLIA]. Zeitschrift fur Kinderheilkunde. 1964 Sep 16:90():301-20     [PubMed PMID: 14316612]


[3]

Oyamada MK, Ferreira HS, Hoff M. Pfeiffer Syndrome type 2--case report. Sao Paulo medical journal = Revista paulista de medicina. 2003 Jul 1:121(4):176-9     [PubMed PMID: 14595512]

Level 3 (low-level) evidence

[4]

Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D, Le Merrer M, Bonaventure J. Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. European journal of human genetics : EJHG. 2006 Mar:14(3):289-98     [PubMed PMID: 16418739]

Level 2 (mid-level) evidence

[5]

Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature genetics. 1994 Nov:8(3):269-74     [PubMed PMID: 7874169]


[6]

Vogels A, Fryns JP. Pfeiffer syndrome. Orphanet journal of rare diseases. 2006 Jun 1:1():19     [PubMed PMID: 16740155]


[7]

Herman TE, Siegel MJ. Pfeiffer syndrome, type II. Journal of perinatology : official journal of the California Perinatal Association. 2001 Dec:21(8):565-7     [PubMed PMID: 11774022]

Level 3 (low-level) evidence

[8]

Pfeifer CM. Kleeblattschädel in Pfeiffer syndrome type II. Radiology case reports. 2020 May:15(5):474-478. doi: 10.1016/j.radcr.2020.01.034. Epub 2020 Feb 24     [PubMed PMID: 32128008]

Level 3 (low-level) evidence

[9]

Hockstein NG, McDonald-McGinn D, Zackai E, Bartlett S, Huff DS, Jacobs IN. Tracheal anomalies in Pfeiffer syndrome. Archives of otolaryngology--head & neck surgery. 2004 Nov:130(11):1298-302     [PubMed PMID: 15545585]

Level 2 (mid-level) evidence

[10]

Mahmud N, Abdul Latif H, Mohd Zaki F, Goh BS. Tracheal cartilaginous sleeve in Pfeiffer syndrome: lesson learnt from its rarity. BMJ case reports. 2021 Apr 2:14(4):. doi: 10.1136/bcr-2020-236888. Epub 2021 Apr 2     [PubMed PMID: 33811090]

Level 3 (low-level) evidence

[11]

Mavridis IN, Rodrigues D. Nervous system involvement in Pfeiffer syndrome. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2021 Feb:37(2):367-374. doi: 10.1007/s00381-020-04934-7. Epub 2020 Oct 20     [PubMed PMID: 33083874]


[12]

Khonsari RH, Delezoide AL, Kang W, Hébert JM, Bessières B, Bodiguel V, Collet C, Legeai-Mallet L, Sharpe PT, Fallet-Bianco C. Central nervous system malformations and deformations in FGFR2-related craniosynostosis. American journal of medical genetics. Part A. 2012 Nov:158A(11):2797-806. doi: 10.1002/ajmg.a.35598. Epub 2012 Sep 17     [PubMed PMID: 22987770]


[13]

Florisson JM, Dudink J, Koning IV, Hop WC, van Veelen ML, Mathijssen IM, Lequin MH. Assessment of white matter microstructural integrity in children with syndromic craniosynostosis: a diffusion-tensor imaging study. Radiology. 2011 Nov:261(2):534-41. doi: 10.1148/radiol.11101024. Epub 2011 Aug 18     [PubMed PMID: 21852568]


[14]

Ranger A, Al-Hayek A, Matic D. Chiari type 1 malformation in an infant with type 2 Pfeiffer syndrome: further evidence of acquired pathogenesis. The Journal of craniofacial surgery. 2010 Mar:21(2):427-31. doi: 10.1097/SCS.0b013e3181cfa792. Epub     [PubMed PMID: 20186072]


[15]

Raybaud C, Di Rocco C. Brain malformation in syndromic craniosynostoses, a primary disorder of white matter: a review. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2007 Dec:23(12):1379-88     [PubMed PMID: 17882438]


[16]

Boulet C, Schiettecatte A, De Mey J, De Maeseneer M. Case report: imaging findings in a "butterfly" vertebra. Acta neurologica Belgica. 2011 Dec:111(4):344-8     [PubMed PMID: 22368979]

Level 3 (low-level) evidence

[17]

Dobson LJ, Barnewolt CE, Morash D, Connolly SA, Estroff JA. Human fetal sacrococcygeal extension or 'tail' in the second trimester: prenatal diagnosis, associated findings, and clinical outcome. Prenatal diagnosis. 2013 Feb:33(2):134-40. doi: 10.1002/pd.4021. Epub 2012 Dec 17     [PubMed PMID: 23255174]

Level 2 (mid-level) evidence

[18]

Clark JD, Compton CJ, Tahiri Y, Nunery WR, Harold Lee HB. Ophthalmic considerations in patients with Pfeiffer syndrome. American journal of ophthalmology case reports. 2016 Jul:2():1-3. doi: 10.1016/j.ajoc.2016.04.001. Epub 2016 Apr 7     [PubMed PMID: 29503887]

Level 3 (low-level) evidence

[19]

Medina M, Cortés E, Eguiluz I, Barber MA. Three-dimensional features of Pfeiffer syndrome. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2009 Jun:105(3):266-7. doi: 10.1016/j.ijgo.2009.01.011. Epub 2009 Feb 20     [PubMed PMID: 19232609]

Level 3 (low-level) evidence

[20]

Wanner MR, Marine MB, Dahl JP. Ultrasound diagnosis of tracheal cartilaginous sleeve in a patient with Pfeiffer syndrome. Pediatric radiology. 2018 Nov:48(12):1814-1816. doi: 10.1007/s00247-018-4207-8. Epub 2018 Jul 19     [PubMed PMID: 30022259]


[21]

Loy KA, Lam AS, Otjen JP, Dahl JP. Tracheal cartilaginous sleeve diagnosed on ultrasound in a child with Pfeiffer syndrome. International journal of pediatric otorhinolaryngology. 2020 Nov:138():110321. doi: 10.1016/j.ijporl.2020.110321. Epub 2020 Aug 17     [PubMed PMID: 32877875]


[22]

Vimercati A, Olivieri C, Dellino M, Gentile M, Tinelli R, Cicinelli E. Prenatal diagnosis of Pfeiffer syndrome and role of three-dimensional ultrasound: case report and review of literature. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2022 Dec:35(25):7840-7843. doi: 10.1080/14767058.2021.1937984. Epub 2021 Jun 28     [PubMed PMID: 34182859]

Level 3 (low-level) evidence

[23]

Tie HX, Li TG, Xu FR, Wu WR, Ma B. An early prenatal diagnosis of type III Pfeiffer syndrome: a case description. Quantitative imaging in medicine and surgery. 2024 Dec 5:14(12):9835-9840. doi: 10.21037/qims-24-440. Epub 2024 Jul 9     [PubMed PMID: 39698725]

Level 2 (mid-level) evidence

[24]

Kroczek RA, Mühlbauer W, Zimmermann I. Cloverleaf skull associated with Pfeiffer syndrome: pathology and management. European journal of pediatrics. 1986 Oct:145(5):442-5     [PubMed PMID: 3792393]

Level 3 (low-level) evidence

[25]

Park MS, Yoo JE, Chung J, Yoon SH. A case of Pfeiffer syndrome. Journal of Korean medical science. 2006 Apr:21(2):374-8     [PubMed PMID: 16614535]

Level 3 (low-level) evidence

[26]

Raposo-Amaral CE, Denadai R, Máximo G, Raposo-Amaral CA, Ghizoni E. Pfeiffer Syndrome: A Therapeutic Algorithm Based on a Modified Grading Scale. Plastic and reconstructive surgery. Global open. 2020 Apr:8(4):e2788. doi: 10.1097/GOX.0000000000002788. Epub 2020 Apr 29     [PubMed PMID: 32440448]


[27]

Jönsson S, Nilsson D, Tarnow P, Maltese G, Bhatti-Søfteland M, Kölby L, Hallén T. Prevalence and treatment outcomes of hydrocephalus among children with craniofacial syndromes. Journal of plastic surgery and hand surgery. 2025 Feb 20:60():40-45. doi: 10.2340/jphs.v60.42957. Epub 2025 Feb 20     [PubMed PMID: 39976487]


[28]

Lee C, Alhaj Z, Almubaid Z, Kichili N, Mohamed S. Prolonged Ventilator Dependency in a Pediatric ICU Patient With Pfeiffer Syndrome Following Le Fort I Osteotomy and Distraction Osteogenesis: A Case Report. Cureus. 2024 Oct:16(10):e71617. doi: 10.7759/cureus.71617. Epub 2024 Oct 16     [PubMed PMID: 39553148]

Level 3 (low-level) evidence

[29]

Morray JP, Geiduschek JM, Ramamoorthy C, Haberkern CM, Hackel A, Caplan RA, Domino KB, Posner K, Cheney FW. Anesthesia-related cardiac arrest in children: initial findings of the Pediatric Perioperative Cardiac Arrest (POCA) Registry. Anesthesiology. 2000 Jul:93(1):6-14     [PubMed PMID: 10861140]